home / stock / mynd:cc / mynd:cc news


MYND:CC News and Press, Mynd Life Sciences Inc.

Stock Information

Company Name: Mynd Life Sciences Inc.
Stock Symbol: MYND:CC
Market: CNQC
Website: myndsciences.com

Menu

Get MYND:CC Alerts

News, Short Squeeze, Breakout and More Instantly...

MYND:CC - CSE Bulletin: Suspension - MYND Life Sciences Inc. (MYND)

Toronto, Ontario--(Newsfile Corp. - Le 1 mai/May 2025) - Effective immediately, MYND Life Sciences Inc. is suspended pursuant to CSE Policy 3. The suspension is considered a Regulatory Halt as defined in National Instrument 23-101 Trading Rules. A cease trade order has been issued by the British ...

MYND:CC - Canadian Investment Regulatory Organization Trading Halt - MYND

Canadian Investment Regulatory Organization Trading Halt - MYND Canada NewsWire VANCOUVER, BC , May 1, 2025 /CNW/ - The following issues have been halted by CIRO: Company: MYND Life Sciences Inc. CSE Symbol: MYND All Issues: Yes Reason: Cease Tra...

MYND:CC - Management Cease Trade Order Status Report

Vancouver, British Columbia--(Newsfile Corp. - March 24, 2025) - MYND Life Sciences Inc. (CSE: MYND) ("MYND" or the "Company") announced on March 3, 2025, the Company was granted a management cease trade order (MCTO) under the National Policy 12-203 of the Canadian Securities Administrators ("NP ...

MYND:CC - Management Cease Trade Order Granted

Vancouver, British Columbia--(Newsfile Corp. - March 3, 2025) - Mynd Life Sciences Inc. (CNSX: MYND) ("Mynd" or the "Company") announces that it has been advised by its external auditors (the "Auditors") that they will not be in a position to complete their work on the Company's annual consolidat...

MYND:CC - MYND Life Sciences Announces Shares for Debt Transaction

Vancouver, British Columbia--(Newsfile Corp. - February 11, 2025) - MYND Life Sciences Inc. (CSE: MYND) (OTC Pink: MYNDF) (" MYND " or the " Company ") a clinical-stage life sciences company committed to the development and commercialization of drug therapies and diagnostics to improve the moni...

MYND:CC - MYND Life Sciences Announces the Issuance of 4,000,001 Shares at $0.71/share

Vancouver, British Columbia--(Newsfile Corp. - January 17, 2025) - MYND Life Sciences (CSE: MYND) (OTC Pink: MYNDF) (" MYND " or the " Company ") a clinical-stage life sciences company committed to the development and commercialization of drug therapies and diagnostics to improve the monitoring...

MYND:CC - MYND Life Sciences Announces Successful Conclusion of Debenture Settlement Agreement and Leadership Transition

Vancouver, British Columbia--(Newsfile Corp. - January 10, 2025) - MYND Life Sciences (CSE: MYND) (OTC Pink: MYNDF) (" MYND " or the " Company ") a clinical-stage life sciences company committed to the development and commercialization of a biomarker tool for monitoring depression, today announ...

Next 10